Global Non-PVC IV Bag Market Forecast and Analysis 2016-2021
Non-PVC IV bags are intravenous bags made of non-PVC (non-polyvinyl chloride) film. The non-PVC IV bag multilayer co-squeezed film are mainly PP, SEBS, PB, SEBS-PE, PP, PET, PA, PS, PC, etc. Due to its advantages other than safety and compatibility of drug products, the non-PVC infusion bag has strengths on the market and gains its popularity. First, the infusion bag can be emptied autonomously during infusion to avoid secondary pollution caused by introduction of ambient air. Secondly, it is lightweight, impact resistant and unlikely to fall for convenience of transportation. Thanks for its superior safety and chemical stability, the application of Non-PVC film is greatly extended, from routine IV solution in the earlier phase such as glucose injection and sodium chloride solution, to current electrolyte injection, nutrient injection and injection for treatment with high added value.
The global Non-PVC IV bag production, which measures output worldwide, was expected to reach xx million units in 2016 with an increase of xx% from its year-earlier level. The global Non-PVC IV bag market size is estimated to grow from USD xx million in 2011 to USD xx million by 2016, at an estimated CAGR of xx% between 2011 and 2016. With regards to this, key players of Non-PVC IV bag industry are expected to find potential opportunities in this market.
The global Non-PVC IV bag market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Non-PVC IV bag market are Baxter, Fresenius Group, B.Braun, Otsuka, Hospira, Cisen Pharmaceutical, CR Double-Crane, Huaren Pharmaceutical, Shijiazhuang No.4, Kelun Group among others.
The global Non-PVC IV bag industry is relatively concentrated, with the market share of top 10 Non-PVC IV bag producers at xx%.
The global Non-PVC IV bag production, which measures output worldwide, was expected to reach xx million units in 2016 with an increase of xx% from its year-earlier level. The global Non-PVC IV bag market size is estimated to grow from USD xx million in 2011 to USD xx million by 2016, at an estimated CAGR of xx% between 2011 and 2016. With regards to this, key players of Non-PVC IV bag industry are expected to find potential opportunities in this market.
The global Non-PVC IV bag market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Non-PVC IV bag market are Baxter, Fresenius Group, B.Braun, Otsuka, Hospira, Cisen Pharmaceutical, CR Double-Crane, Huaren Pharmaceutical, Shijiazhuang No.4, Kelun Group among others.
The global Non-PVC IV bag industry is relatively concentrated, with the market share of top 10 Non-PVC IV bag producers at xx%.
PREFACE
PART 1. SCOPE OF REPORT
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
PART 2. INTRODUCTION
2.1 Definition
2.2 IV Bag Development
2.3 Current Scenario
PART 3 VALUE CHAIN ANALYSIS
3.1 Upstream
3.1.1 Non-PVC Film
3.2 Downstream
PART 4. MANUFACTURE
4.1 Manufacturing Process
4.2 Manufacturing Costs
PART 5. COMPANY PROFILES
5.1 Baxter (USA)
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Hospira (USA)
5.2.1 Business Overview
5.2.2 Products Offered
5.2.3 Business Performance
5.3 Fresenius Group (Germany)
5.3.1 Business Overview
5.3.2 Products Offered
5.3.3 Business Performance
5.4 B.Braun (Germany)
5.4.1 Business Overview
5.4.2 Products Offered
5.4.3 Business Performance
5.5 Otsuka (Japan)
5.5.1 Business Overview
5.5.2 Products Offered
5.5.3 Business Performance
5.6 Kelun Group (China)
5.6.1 Business Overview
5.6.2 Products Offered
5.6.3 Business Performance
5.7 Huaren Pharmaceutical (China)
5.6.1 Business Overview
5.7.2 Products Offered
5.7.3 Business Performance
5.8 CR Double-Crane (China)
5.8.1 Business Overview
5.8.2 Products Offered
5.8.3 Business Performance
5.9 Zhejiang Chimin (China)
5.9.1 Business Overview
5.9.2 Products Offered
5.9.3 Business Performance
5.10 Cisen Pharmaceutical (China)
5.10.1 Business Overview
5.10.2 Products Offered
5.10.3 Business Performance
5.11 Liuan Worldbest (China)
5.11.1 Business Overview
5.11.2 Products Offered
5.11.3 Business Performance
5.12 Shandong Hualu (China)
5.12.1 Business Overview
5.12.2 Products Offered
5.12.3 Business Performance
5.13 Shijiazhuang No.4 Pharmaceutical (China)
5.13.1 Business Overview
5.13.2 Products Offered
5.13.3 Business Performance
5.14 BBCA Pharmaceutical (China)
5.14.1 Business Overview
5.14.2 Products Offered
5.14.3 Business Performance
5.15 Hunan Jinjian (China)
5.15.1 Business Overview
5.15.2 Products Offered
5.15.3 Business Performance
5.16 Kunming Yusi (China)
5.16.1 Business Overview
5.16.2 Business Performance
PART 6. MARKET OVERVIEW
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 China
6.2.2 North America
6.2.3 EMEA
6.2.4 Asia-Pacific (ex-China)
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 China
6.4.2 North America
6.4.3 EMEA
6.4.4 Asia-Pacific (ex-China)
PART 7. CONSUMPTION PATTERN
7.1 Regional Consumption
7.1.1 China
7.1.2 North America
7.1.3 EMEA
7.1.4 Asia-Pacific (ex-China)
7.2 Global Consumption by Application
7.3 Chinese Consumption by Application
PART 8. MARKET FORECAST
8.1 Market Size Forecast
8.1.1 Market Size by Volume (M Units)
8.1.2 Market Size by Value (M USD)
8.2 Regional Consumption Forecast
8.2.1 China
8.2.2 North America
8.2.3 EMEA
8.2.4 Asia-Pacific (ex-China)
8.3 Consumption Forecast by Application
PART 9. MARKET DYNAMICS
9.1 Market Drivers
9.1.1 Increasing Popularity
9.1.2 Demand in Developing Countries
9.1.3 PVC Replacement
9.1.4 Glass, Bottle Container Replacement
9.2 Market Constraints
9.2.1 Entry Barriers
9.2.2 Policy
9.2.3 Product Liability
9.2.4 Rising Labor Costs
9.2.5 Exchange Rate
9.2 Market Strategies
9.3 Key Events
PART 10. INVESTMENT FEASIBILITY
10.1 Global Economic Highlight 2015
10.2 Recent Developments
10.3 The Updated Forecast
10.3.1 Advanced Economies
10.3.2 Emerging Market and Developing Economies
10.4 China Outlook 2016
10.5 Investment in China
10.5.1 Outlook on investment
10.5.2 Growth opportunities
10.5.3 Policy Trends
10.5.4 Conclusions
10.6 Feasibility of New Project
10.6.1 Basis and Presumptions
10.6.2 New Project in China
12. DISCLAIMER
12. ANALYST(S) CERTIFICATION
PART 1. SCOPE OF REPORT
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
PART 2. INTRODUCTION
2.1 Definition
2.2 IV Bag Development
2.3 Current Scenario
PART 3 VALUE CHAIN ANALYSIS
3.1 Upstream
3.1.1 Non-PVC Film
3.2 Downstream
PART 4. MANUFACTURE
4.1 Manufacturing Process
4.2 Manufacturing Costs
PART 5. COMPANY PROFILES
5.1 Baxter (USA)
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Hospira (USA)
5.2.1 Business Overview
5.2.2 Products Offered
5.2.3 Business Performance
5.3 Fresenius Group (Germany)
5.3.1 Business Overview
5.3.2 Products Offered
5.3.3 Business Performance
5.4 B.Braun (Germany)
5.4.1 Business Overview
5.4.2 Products Offered
5.4.3 Business Performance
5.5 Otsuka (Japan)
5.5.1 Business Overview
5.5.2 Products Offered
5.5.3 Business Performance
5.6 Kelun Group (China)
5.6.1 Business Overview
5.6.2 Products Offered
5.6.3 Business Performance
5.7 Huaren Pharmaceutical (China)
5.6.1 Business Overview
5.7.2 Products Offered
5.7.3 Business Performance
5.8 CR Double-Crane (China)
5.8.1 Business Overview
5.8.2 Products Offered
5.8.3 Business Performance
5.9 Zhejiang Chimin (China)
5.9.1 Business Overview
5.9.2 Products Offered
5.9.3 Business Performance
5.10 Cisen Pharmaceutical (China)
5.10.1 Business Overview
5.10.2 Products Offered
5.10.3 Business Performance
5.11 Liuan Worldbest (China)
5.11.1 Business Overview
5.11.2 Products Offered
5.11.3 Business Performance
5.12 Shandong Hualu (China)
5.12.1 Business Overview
5.12.2 Products Offered
5.12.3 Business Performance
5.13 Shijiazhuang No.4 Pharmaceutical (China)
5.13.1 Business Overview
5.13.2 Products Offered
5.13.3 Business Performance
5.14 BBCA Pharmaceutical (China)
5.14.1 Business Overview
5.14.2 Products Offered
5.14.3 Business Performance
5.15 Hunan Jinjian (China)
5.15.1 Business Overview
5.15.2 Products Offered
5.15.3 Business Performance
5.16 Kunming Yusi (China)
5.16.1 Business Overview
5.16.2 Business Performance
PART 6. MARKET OVERVIEW
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 China
6.2.2 North America
6.2.3 EMEA
6.2.4 Asia-Pacific (ex-China)
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 China
6.4.2 North America
6.4.3 EMEA
6.4.4 Asia-Pacific (ex-China)
PART 7. CONSUMPTION PATTERN
7.1 Regional Consumption
7.1.1 China
7.1.2 North America
7.1.3 EMEA
7.1.4 Asia-Pacific (ex-China)
7.2 Global Consumption by Application
7.3 Chinese Consumption by Application
PART 8. MARKET FORECAST
8.1 Market Size Forecast
8.1.1 Market Size by Volume (M Units)
8.1.2 Market Size by Value (M USD)
8.2 Regional Consumption Forecast
8.2.1 China
8.2.2 North America
8.2.3 EMEA
8.2.4 Asia-Pacific (ex-China)
8.3 Consumption Forecast by Application
PART 9. MARKET DYNAMICS
9.1 Market Drivers
9.1.1 Increasing Popularity
9.1.2 Demand in Developing Countries
9.1.3 PVC Replacement
9.1.4 Glass, Bottle Container Replacement
9.2 Market Constraints
9.2.1 Entry Barriers
9.2.2 Policy
9.2.3 Product Liability
9.2.4 Rising Labor Costs
9.2.5 Exchange Rate
9.2 Market Strategies
9.3 Key Events
PART 10. INVESTMENT FEASIBILITY
10.1 Global Economic Highlight 2015
10.2 Recent Developments
10.3 The Updated Forecast
10.3.1 Advanced Economies
10.3.2 Emerging Market and Developing Economies
10.4 China Outlook 2016
10.5 Investment in China
10.5.1 Outlook on investment
10.5.2 Growth opportunities
10.5.3 Policy Trends
10.5.4 Conclusions
10.6 Feasibility of New Project
10.6.1 Basis and Presumptions
10.6.2 New Project in China
12. DISCLAIMER
12. ANALYST(S) CERTIFICATION